Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in VERU — Veru Inc.

CIK 72971 SAN FRANCISCO, CA
Back to VERU Full portfolio

Position in VERU

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$21,863
+$6,382 QoQ
Shares Held
6,985
-0.3% QoQ
Ownership
0.041%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 61 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VERU Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. VERU ranks #308 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in VERU

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $21,863 6,985
2026-03-31 $15,481 7,005
2025-12-31 $759 355
2025-09-30 $3,416 899
2025-06-30 $6,267 10,807
2025-03-31 $36,113 73,704
2024-12-31 $49,082 75,512
2024-09-30 $42,411 55,082
2024-06-30 $48,047 57,200
2024-03-31 $6,635 9,479
2023-12-31 $6,505 9,036
2023-09-30 $9,056 12,580
2023-06-30 $14,650 12,312
2023-03-31 $31,161 26,864
2022-12-31 $76,190 14,430
2022-09-30 $181,220 15,731
2022-06-30 $157,452 13,934
2022-03-31 $124,183 25,711
2021-12-31 $267,093 45,347
2021-09-30 $46,062 5,400
2021-06-30 $50,598 6,270
2021-03-31 $225,538 20,922
2020-12-31 $1,133,011 130,984
2020-09-30 $413,885 157,972
2020-06-30 $556,045 166,481
2020-03-31 $421,386 128,865